Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Metastatic; Quality of life; QoL; Progression;
مقالات ISI سرطان پستان پیشرفته (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان پستان پیشرفته; Global analysis; Advanced breast cancer; Metastatic breast cancer;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; PI3K inhibitor; Progression-free survival; Toxicity; Systematic review; Meta-analysis;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Bone metastasis; ESR1; Gene expression profile; NanoString microarray;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Survivorship; Care-givers; Palliative care; Quality of life;
Keywords: سرطان پستان پیشرفته; Mammography screening; Advanced breast cancer; Screening attendance; Self-selection bias; Cohort study; Screening effectiveness;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Palbociclib; Letrozole; Cost-utility; Cost-effectiveness;
Keywords: سرطان پستان پیشرفته; ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: سرطان پستان پیشرفته; Clinical trials; Advanced breast cancer; Trial registration; Reporting; Publication; Publication bias;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Metastatic breast cancer; Survey; Emotional need; Psychosocial need; Information need;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Adverse events; Chemotherapy; Endocrine therapy; Postmenopausal;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Bone metastasis; Hormone receptor positivity; Overall survival; Progression-free survival;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Zambia; Experiences
Keywords: سرطان پستان پیشرفته; CTC; circulating tumour cell; MBC; metastatic breast cancer; CVB; central venous blood; PVB; peripheral venous blood; TCE; tumour cell emboli; ABC; advanced breast cancer; RT-qPCR; reverse transcription quantitative real-time polymerase chain reaction; Ci
Keywords: سرطان پستان پیشرفته; Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Endocrine therapy; Estrogen receptor; Postmenopausal; Tumor biomarkers;
Keywords: سرطان پستان پیشرفته; Breast cancer; Adverse events; Trastuzumab; Pertuzumab; Lapatinib; Bevacizumab; Trastuzumab-emtansine; Everolimus; ABC; advanced breast cancer; QoL; quality of life; AE; adverse event; HER2; human epidermal growth factor receptor type 2; LVEF; left ventri
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; First-line; Fulvestrant; Second-line; Overall survival;
HER2-positive breast cancer: Current and new therapeutic strategies
Keywords: سرطان پستان پیشرفته; HER2 positive; Targeted therapies; Drugs in development; Advanced breast cancer;
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Metastatic; Chemotherapy; Antihormone therapy; Aromatase inhibitor; Fulvestrant; Tamoxifen; Everolimus; Therapy/treatment sequence;
Treatment of advanced HER2-positive breast cancer: 2018 and beyond
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; HER2-positive disease; Anti-HER2 treatment;
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3
Keywords: سرطان پستان پیشرفته; Palbociclib; Fulvestrant; Advanced breast cancer; HR+/HER2-; Long-term response;
Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Age; HR-positive; Endocrine treatment; HER2-negative; Tumour; Letrozole; Fulvestrant; Palbociclib;
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Endocrine therapy; Everolimus; Hormone receptor-positive; Letrozole;
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Dasatinib; Metastatic breast cancer; Paclitaxel; SRC;
Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. AÂ Multicenter Phase II Trial by the Hellenic Oncology Research Group
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Angiogenesis; Chemotherapy; Platinum; VEGF;
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Clinical trial; Overall survival; Progression-free survival; Time to progression;
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2â) advanced breast cancer patients: New insights beyond clinical trials. The EVA study
Keywords: سرطان پستان پیشرفته; Everolimus; Hormone-receptor positive; Advanced breast cancer; Fulvestrant; Dose-intensity;
CDK4/6 inhibitors in HER2-positive breast cancer
Keywords: سرطان پستان پیشرفته; Breast cancer; Advanced breast cancer; HER2 positive BC; Cyclin-dependent kinases (CDK); Palbociclib; Ribociclib; Abemaciclib;
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort study
Keywords: سرطان پستان پیشرفته; Breast neoplasms; Cohort studies; Palliative care; Outpatients; Real-world data; Registries; ABC; advanced breast cancer; AGO; Arbeitsgemeinschaft Gynäkologische Onkologie; Bev; bevacizumab; C; cyclophosphamid; Cap; capecitabine; Car; carboplatin; CCI; C
Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; metastatic breast cancer; health-related quality of life; real-world; treatment satisfaction;
Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Etirinotecan pegol; Metastatic breast cancer; NKTR-102; Quality of life;
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Cyclin-dependent kinase 4/6 inhibitor; Endocrine therapy; Hormone receptor-positive; PI3K/mTOR inhibitor;
Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Anthracyclines; Pegylated liposomal doxorubicin (PLD); Phase II Trial;
Endocrine therapy for hormone treatment-naïve advanced breast cancer
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Metastatic breast cancer; Endocrine therapy; Endocrine therapy-naïve; CBR; clinical benefit rate; CDK; cyclin-dependent kinase; CI; confidence interval; ER; estrogen receptor; HER; human epidermal growth factor receptor; HR; hazar
Impacto pronóstico de la respuesta patológica completa y del estado ganglionar en pacientes con cáncer de mama avanzado tratadas con dosis alta de epirrubicina neoadyuvante
Keywords: سرطان پستان پیشرفته; Quimioterapia neoadyuvante; Respuesta patológica completa; Cáncer de mama avanzadoNeoadjuvant chemotherapy; Pathological complete response; Advanced breast cancer
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature
Keywords: سرطان پستان پیشرفته; Advanced Breast cancer; Her2 positive; Treatment; Trastuzumab emtansine
Dosing of zoledronic acid with its anti-tumor effects in breast cancer
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Bone metastases; Zoledronic acid; N-telopeptide; Prognosis
Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Everolimus; Clinical practice;
Tumeurs du sein luminales (récepteurs hormonaux positifs, HER2 négatives) au stade avancé : les nouvelles options thérapeutiques en 2015
Keywords: سرطان پستان پیشرفته; Cancer du sein; hormonosensible; Hormonothérapie; Thérapies moléculaires; ciblées; Hormone; receptor-positive; advanced breast cancer; Hormone therapy; Targeted therapy;
Challenges in optimizing care in advanced breast cancer patients: Results of an international survey linked to the ABC1 consensus conference
Keywords: سرطان پستان پیشرفته; Consensus guidelines; Advanced breast cancer; Survey; Metastatic breast cancer; ABC; advanced breast cancer; EBC; early breast cancer; MBC; metastatic breast cancer;
Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Fulvestrant; Selumetinib; Endocrine therapy; MEK 1/2 inhibitor; MAPK pathway;
Original StudyPhase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Breast neoplasm; Chemotherapy; Nontaxane microtubule dynamics inhibitor; Oncology;
Adverse Event Management of mTOR Inhibitors During Treatment of Hormone Receptor–Positive Advanced Breast Cancer: Considerations for Oncologists
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Adverse events; Everolimus; Infection; mTOR; Noninfectious pneumonitis; Rash; Stomatitis
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Everolimus; Exemestane; Visceral metastases;
Original studySafety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor-Positive Breast Cancer in BOLERO-2
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Endocrine resistance; Geriatric; Progression-free survival; Safety;
Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer
Keywords: سرطان پستان پیشرفته; Vinflunine; Advanced breast cancer; Phase II; Single agent
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach
Keywords: سرطان پستان پیشرفته; Inflammatory breast cancer; Level of evidence; Advanced breast cancer; Multimodality treatment; Bolus
Changing Concepts of Hormone Receptor-Positive Advanced Breast Cancer Therapy
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Endocrine therapy; Everolimus;
mTOR inhibitors in advanced breast cancer: Ready for prime time?
Keywords: سرطان پستان پیشرفته; Advanced breast cancer; Endocrine resistance; Estrogen receptor; Everolimus; Exemestane; Human epidermal growth factor receptor-2; mTOR inhibitor; Progesterone receptor